Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...
Using a large population-based cohort of users of anti-Parkinsonian drugs, we found that the use of pramipexole is not associated with an increase in the risk of severe pneumonia requiring ...
Mice with Parkinson’s Disease and treated with pramipexole show poor decision-making skills in a gambling task, as seen on the left. This is caused by increased activity in the external globus ...